Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
-
- STATUS
- Recruiting
-
- End date
- Aug 1, 2021
-
- participants needed
- 1000
-
- sponsor
- Phathom Pharmaceuticals, Inc.
Updated on 16 December 2020
Phathom Medical Information
Primary Contact
Clinical Associates Research (7.7 mi away) Contact
+126 other locationSummary
To evaluate the efficacy and safety of vonoprazan compared to lansoprazole in participants with erosive esophagitis.
Details
| Treatment | lansoprazole, Vonoprazan |
|---|---|
| Clinical Study Identifier | NCT04124926 |
| Sponsor | Phathom Pharmaceuticals, Inc. |
| Last Modified on | 16 December 2020 |
How clear was the trial content above?
Hard
Easy
Adding a note
Select a piece of text and start making personal notes.
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer